Journal article
Adherence to Lenalidomide in Older Adults With Newly Diagnosed Multiple Myeloma
Abstract
INTRODUCTION: One of the most common orally administered antimyeloma agents, lenalidomide, has significantly improved outcomes in multiple myeloma, including in older patients. However, despite its utilization and cost, the rates and factors related to adherence to lenalidomide in older adults with newly diagnosed multiple myeloma remain unknown.
PATIENTS AND METHODS: Data were collected from adults with newly diagnosed multiple myeloma over …
Authors
Mian H; Fiala M; Wildes TM
Journal
Clinical Lymphoma Myeloma & Leukemia, Vol. 20, No. 2, pp. 98–104.e1
Publisher
Elsevier
Publication Date
February 2020
DOI
10.1016/j.clml.2019.09.618
ISSN
2152-2650